Medicare Enrolled

Dr. Chaturani Ranasinghe, M.D.

Internal Medicine · Marco Island, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
606 BALD EAGLE DR STE 610, Marco Island, FL 34145
2396102111
In practice since 2007 (19 years)
NPI: 1144370693 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ranasinghe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ranasinghe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ranasinghe

Dr. Chaturani Ranasinghe is an internal medicine specialist in Marco Island, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ranasinghe performed 3,280 Medicare services across 1,374 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ranasinghe received a total of $2,145 from 29 pharmaceutical and/or device companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ranasinghe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 13% volume in FL $2,145 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 113162 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
3,280
Medicare services
Top 13% in FL for internal medicine
1,374
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~173 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,219 $1 $3
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
532 $97 $267
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
251 $0 $1
Contrast dye for imaging, lower concentration 234 $0 $1
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
152 $127 $354
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
139 $70 $191
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
129 $179 $582
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
127 $93 $302
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
122 $205 $553
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
76 $205 $589
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
57 $41 $116
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
40 $354 $946
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
40 $12 $26
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
38 $195 $520
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
33 $146 $438
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
25 $149 $407
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
25 $78 $206
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
23 $56 $245
Spinal and pelvic nerve injection with imaging guidance
An anesthetic and/or steroid medication is injected into nerves in the spine or pelvis while using imaging to guide the needle placement.
18 $165 $489
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,145
Total received (2018-2024)
Avg $306/year across 7 years
Top 25% in FL for internal medicine
29
Companies
85
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,145 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$128
2023
$281
2022
$60
2021
$121
2020
$287
2019
$334
2018
$934

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$361
Flexion Therapeutics, Inc.
$208
Avanos Medical
$203
Boston Scientific Corporation
$183
Abbott Laboratories
$181
Scilex Pharmaceuticals Inc.
$147
Amgen Inc.
$116
Medtronic USA, Inc.
$93
SCILEX PHARMACEUTICALS INC.
$84
PFIZER INC.
$59
Collegium Pharmaceutical, Inc.
$48
Teva Pharmaceuticals USA, Inc.
$43
Merck Sharp & Dohme LLC
$42
GRT US Holding, Inc.
$36
Nuvectra Corporation
$36
Stimwave Technologies Incorporated
$34
Novartis Pharmaceuticals Corporation
$34
TerSera Therapeutics LLC
$32
Daiichi Sankyo Inc.
$29
SI-BONE, INC.
$27
Allergan, Inc.
$26
Horizon Therapeutics plc
$24
Stratus Medical, LLC
$23
ABBVIE INC.
$16
Averitas Pharma Inc.
$15
Fidia Pharma USA Inc.
$13
Sentynl Therapeutics, Inc.
$13
FIDIA PHARMA USA INC.
$12
AbbVie Inc.
$11
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Algovita · BOTOX · CFNS StimQ Peripheral Nerve StimulatorSystem · COOLIEF COOLED RADIOFREQUENCY · COOLIEF* COOLED RADIOFREQUENCY · Enhertu · GENERAL PAIN MANAGEMENT · GENERATOR · HYMOVIS · Hymovis · INTELLIS · KEYTRUDA · LYRICA · Levorphanol Tartrate · Nimbus · ON-Q PUMP AND ACCESSORIES · Octrode SCS Leads · PENNSAID · Proclaim Family of SCS IPGs · Prolia · QUTENZA · Qutenza · SCS leads · Senza Spinal Cord Stimulation System · UBRELVY · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $65 per 100 Medicare services performed
Looking for an internal medicine specialist in Marco Island?
Compare internal medicine physicians in the Marco Island area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
200
Per 100K population
51.6
County median income
$86,173
Nearest hospital
WILLOUGH AT NAPLES, THE
9.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ranasinghe is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ranasinghe experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Ranasinghe performed 1,219 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ranasinghe receive payments from pharmaceutical companies?
Yes. Dr. Ranasinghe received a total of $2,145 from 29 companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ranasinghe's costs compare to other internal medicine physicians in Marco Island?
Dr. Ranasinghe's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ranasinghe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →